Nature of Our Reviews & Rankings

What a review here is

A review is our judgment, built from documents anyone can pull. The raw material is a seller's own published pricing, the trial literature behind whatever molecule it sells, state licensing records, pharmacy registries, and federal enforcement files. On most of the register we have also walked the signup ourselves, up to the point where a real order would be placed, and written down what the intake asked and what it skipped.

Nothing is dispensed, prescribed, shipped or insured from here. No drug manufacturer pays us, and none has any say in what gets covered or how a molecule is described. What we do earn is an affiliate commission from some of the telehealth companies in the register, on the ordinary terms those companies offer publishers.

What a review here is not

• Medical advice, for you or for anyone.
• Any kind of stand-in for a clinician who has your history in front of them.
• A complete map of the market. Plenty of sellers are not in the register.
• Guaranteed current. A price, a state list or a feature can move between our last check and the moment you load the page, and often does.
• Free of money. Read the Affiliate Disclosure and decide for yourself what to make of it.

Where the number comes from

Six dimensions, fixed weights, one weighted average out of 10. The heaviest two are what a month really costs and how good the evidence is for the molecule being sold. Everything else — the signup, the oversight and pharmacy record, where the seller ships, what happens after the first refill — splits the remainder. A score is held down by what we could verify rather than lifted by who we know, and paying us is not an input to any of it. The weights, the caps, and the reasoning behind each are on the Methodology page.

What a commercial relationship buys

Most comparison sites get vague here. We would rather name it exactly.

Score is independent. Placement is not always. The number attached to a seller comes out of the rubric and the evidence behind it. Two companies with the same record get the same number, and a payout does not move either one.

Order is what money buys, on these surfaces:

• The partner cards on the homepage, the floating widget, and the provider-of-the-month panel. These come from the partner pool and are ordered by what each company earns us, above a score floor that earnings alone do not buy past.
• The reviews directory and the comparison tool, where partners are grouped ahead of everyone else and ranked normally inside each group.
• The head of the boards with the strongest buying intent: the semaglutide and tirzepatide lists, compounded and otherwise, the injection and shot lists, fitness apps, and the ED, TRT and HRT boards.
• The “Top Pick” card on an alternatives page, which is drawn from that same partner-first order rather than from rank alone.

A partner marker sits on the listing itself in the reviews directory and on the boards. The comparison tool discloses once at the page level instead. Two places are deliberately off limits to all of it: the two boards ordered purely by price, and the A–Z index, which is alphabetical and nothing else. A seller we earn nothing from is scored by the same rubric, reviewed at the same length, and shows the same full number as a partner does.

The money itself is itemized in the Affiliate Disclosure. What we have promised not to do with it is in the Code of Conduct.

Check these before you pay

Take these to the seller and to your own clinician. Every one of them is a place where the marketing page and the reality routinely part company.

• What it bills, and how often. Read the total on the checkout page, not the headline. An introductory rate lapses, a dose step reprices, and a quoted “month” is sometimes four weeks.
• Whether it can ship to you. Compounding and telehealth rules are set state by state and they move, so a seller's coverage map can be out of date on its own site.
• LegitScript certification. Look up any provider at legitscript.com.
• Who makes the vial. Get the name of the compounding pharmacy in writing, then look it up. A seller that will not name one is telling you something.
• Who signs off. There should be a licensed prescriber weighing your case, and you should be able to tell the difference between that and a form that approves everybody.
• Cold-chain shipping. Semaglutide and tirzepatide need refrigeration; ensure the provider ships with validated cold-chain packaging.
• What your plan will actually do. Many plans exclude weight management outright. Others say yes only after a prior authorization or a round of step therapy, and that is a call your insurer makes, not the seller.
• Interactions and reasons not to take it. This one is not ours to answer. It needs somebody looking at your history and the rest of your medicine cabinet.

Talk to a doctor

Nothing on this site is a substitute for a conversation with a qualified clinician. Before starting, stopping, or changing any medication — especially injectable GLP-1s like semaglutide and tirzepatide — please talk to a licensed healthcare provider. GLP-1 prescribing decisions involve weighing personal medical history, contraindications (pancreatitis history, medullary thyroid carcinoma risk, pregnancy, and more), concurrent medications, and individual risk factors that a comparison site cannot evaluate. A 10/10 score on our rankings does not mean a provider or drug is the right fit for you specifically.

How the register is kept up

• Prices. An automated sweep runs against live seller pages on the first of each month. It stamps a verified date only where the fetched page agreed with what we hold. Drift, an unreadable page or a failed fetch leaves the old record alone and lands on a manual list instead, and a person merges the result.
• FDA warning letters. Scraped from fda.gov twice a month. New letters arrive as a change we review before it publishes.
• Citations. Every cited PubMed ID is re-checked twice a month against the record it claims to be, which catches a retraction or a dead link.
• Everything else in a record. Entity, licensing, states and pharmacy partners are checked by hand, on no fixed clock. Each review carries the month of its last check and a confidence tier, and a low tier means we could not corroborate what the seller says about itself.

None of that makes a figure current at the moment you read it. It makes the age of the figure visible, which is the most a register can honestly offer.

Tell us when we are wrong

A stale price, a state that should not be on a list, a claim that does not hold up: send it to editorial@glpwatchdog.org with the company name and where you saw the right figure. We check it against the source before changing anything, and where a fix changes what a page claimed, the page carries a visible correction stamp rather than being quietly edited.